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Abstract
Global spread of epidemic methicillin-resistant Staphylococcus aureus (MRSA) is an issue of increasing clinical concern especially problematic
community-associated (CA) -MRSA. However, data regarding MRSA epidemiology in regions of the Middle East, including Qatar, are still
insufﬁcient. A representative subset of 61 MRSA isolates from multinational patients from hospital in Qatar during a 2-year period (2009/
2010) was examined. Molecular characterization for MRSA isolates was performed by pulsed-ﬁeld gel electrophoresis (PFGE), SCCmec, spa
and dru typing, and PCR for the presence of the arginine catabolic mobile element and genes for the Panton–Valentine leukocidin (PVL).
Prevalence of MRSA among S. aureus isolated was 176/840 (21%). Of the 61 MRSA isolates examined, three (5%) represented
hospital-acquired infection. By PFGE, 32 isolates (52%) were CA-MRSA USA300 (n = 4), USA400 (n = 3), USA1100/Southwest (SW) Paciﬁc
(n = 17) and ST80-MRSA-IV (n = 8) strains. The remaining isolates were well-known healthcare-associated EMRSA-15 (n = 8) and USA800
(n = 13). Three isolates were USA900, one was USA1200 and four were unrelated to any known strains in the international database.
Unexpectedly, the USA900 isolates were all positive for PVL and USA400 isolates were PVL negative. Five of the eight EMRSA-15 isolates
were PVL positive. ST80-MRSA-IV and USA300 strains exhibited typical dru types (dt10a and dt9g, respectively). Eleven different spa types
were observed in this study. All USA300 isolates were arginine catabolic mobile element positive. The high prevalence of CA-MRSA,
especially including USA300, in this setting underscores the importance of global epidemiological monitoring to better understand and
hopefully help prevent the emergence and spread of these problem pathogens in patient populations.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a patho-
gen of worldwide concern, a cause of morbidity and mortality
in both hospital and community populations. Global spread of
epidemic MRSA is an issue of increasing clinical concern
especially regarding problematic community-associated MRSA.
Several molecular typing techniques have been developed to
provide knowledge of both transmission and epidemiology of
MRSA strains and to support infection control measures [1].
These techniques include pulsed-ﬁeld gel electrophoresis
(PFGE) as a reference standard for MRSA strain typing [2,3],
SCCmec typing [4], as well as DNA sequence-based typing
such as multilocus sequence typing [5], sequencing of the
SCCmec-associated direct repeat unit (dru) [6] and single-locus
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DNA sequencing of repeat regions of the spa gene (protein A)
[7]. Nucleic acid sequence typing has become more popular
than PFGE because of the easy data transfer and excellent
comparability of results through online databases [8].
Panton–Valentine leukocidin (PVL) is an S. aureus-speciﬁc
exotoxin pore-forming protein encoded by two co-transcribed
genes, lukF-PV and lukS-PV, and is associated with skin and
soft-tissue infections and severe necrotizing pneumonia [9].
Healthcare-associated MRSA strains seldom carry PVL, in
contrast community-associated MRSA frequently carries this
gene [10].
The arginine catabolic mobile element (ACME) was shown
to contribute to bacterial growth, survival, transmission and
colonization within the host. Although it is frequently found in
coagulase-negative staphylococcal species, a variety of strains
such as USA300 (ST8-MRSA-IVa) also carry this element [11].
ACME is integrated into orfx, the same site on the S. aureus
chromosome into which SCCmec integrates, and contains the
structural gene arcA with a distinctive nucleotide sequence,
encoding arginine deiminase [12].
Epidemiological data on MRSA in regions of the Middle East,
including Qatar, are still insufﬁcient. The present study was
undertaken to characterize MRSA strains during a 2-year
period (2009/2010) in a private 250-bed tertiary-care general
hospital in Doha, Qatar.
Materials and Methods
Bacterial isolates
A representative subset of 61 MRSA were isolated from
multinational patients in a tertiary-care hospital in Doha,
Qatar over a 2-year period (2009/2010). Only isolates from
patients resident in Doha for > 6 months and who had a
recent history, 3 months before the study, of antibiotic
treatment were selected. Duplicate isolates and isolates with
incomplete clinical data were excluded from the study. All
the isolates were recovered from different patients and
different pathological samples (Table 1). The study was
approved by the hospital ethics and research committee.
MRSA isolates were detected in the clinical laboratory using
VITEK 2 AST-P580 cards (bioMerieux, Marcy l’Etoile,
France), cefoxitin disc diffusion, and PBP2 latex agglutination
(Denka Seiken Co., Niigata, Japan) according to the manu-
facturers’ instructions. Methicillin sensitive S. aureus ATCC
25923 and MRSA ATCC 43300 were used as negative and
positive controls, respectively in each run. Further
conﬁrmation for suspected MRSA isolates was performed
by PCR ampliﬁcation of the mecA gene [13]. All MRSA
isolates were also tested for mupirocin and inducible
clindamycin susceptibility using VITEK 2 AST-P580 cards
according to the manufacturer’s instructions.
Clinical and epidemiological information for patients was
obtained from clinic documents to determine whether these
isolates were recovered from hospital-acquired MRSA or
community-acquired MRSA infections based on patient history
according to the criteria published by the CDC (Atlanta, GA,
USA; http://www.cdc.gov/mrsa/diagnosis/index.html). MRSA
strains were considered to be community-acquired MRSA if
isolates were recovered from outpatients, within 48 h of
hospitalization or if the patient lacked the following hospital-
acquired MRSA risk factors: haemodialysis, surgery, residence
in a long-term care facility or hospitalization during the
previous year, the presence of an indwelling catheter or a
percutaneous device at the time of culture, or previous
isolation of MRSA from the patient.
Molecular characterization
Genomic DNA was extracted by a 10-min incubation with
lysostaphin (0.5 mg/mL) at 37°C followed by boiling for
10 min. After centrifugation, the supernatant was used as a
template for ampliﬁcation. PCR for the presence of the gene
encoding PVL was performed as previously described [14].
ACME-arcA gene was detected by PCR using ACME-speciﬁc
primers [12]. PFGE analysis with SmaI was carried out
according to Goering [15]. Macro-chromosomal restriction
fragments were separated for 23 h at 6 V/cm, using a 120°
included angle at 14°C using a CHEF-DR II System (Bio-Rad,
Hercules, CA, USA), with initial and ﬁnal pulse times of 1 and
35 s, respectively. Staphylococcus aureus 8325 was used as a
reference strain. Banding patterns were analysed with BIO-
NUMERICS V6.5 (Applied Maths, St-Martens-Latem, Belgium)
with unweighted pair-group arithmetic averages (UPGMA) and
Dice coefﬁcients. Band patterns that were >80% identical were
considered related as per the recommendation of Tenover
et al. [3]. PFGE banding patterns were interpreted to different
epidemic-type clones following the published guidelines and
database [16].
SCCmec typing was performed using six multiplex PCR
assays [17,18]. For dru typing, the dru region was ampliﬁed and
sequenced as described previously [19]. The BIONUMERICS
tandem repeat sequence typing plug-in tool was used for dru
sequence analysis and assignment of dru types used an
alphanumeric nomenclature [19]. For spa typing, the primers
and thermal cycling conditions of the European Network of
Laboratories for Sequenced Based Typing of Microbial Patho-
gens (SeqNet [http://www.seqnet.org]) were used. Analysis of
spa sequences and assignment of spa types were performed
using the Spa typing plug-in tool of the BIONUMERICS software
package. Conﬁrmation of sequenced dru and spa types was also
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performed via the freely available dru server (http://www.
dru-typing.org/search.php) and Ridom Spa Server (http://spa.
ridom.de/index.shtml), respectively.
Results and Discussion
A total of 840 S. aureus isolates were recovered from a
tertiary-care hospital in Doha, Qatar over a 2-year period
(2009/2010). The MRSA isolates represent 21% (176
isolates) of the total S. aureus isolated. A subset of 61
MRSA isolates from different multinational patients with a
recent history of antibiotic treatment was chosen for the
current study. According to the CDC criteria, 58 of these
were considered to be community-acquired MRSA based on
patient history whereas the remaining three were hospi-
tal-acquired MRSA from skin infections. Results of molecular
characterization of the isolates by PFGE, and PCR for
SCCmec, PVL, ACME, dru and spa typing are shown in
Table 1 and Fig. 1. There were no signiﬁcant associations
between nationality, age of the patient, or nature of the
specimen and MRSA strain type.
TABLE 1. Clinical and molecular characteristicsa of isolates
Sex Age Specimen Nationality PVL ACME PFGE pattern; SCCmec; dru; spa; Predicted MLST (ST)
F 5 years Throat Egyptian Negative Negative EMRSA 15; SCCmec IV; ND; t852; 22b
F 24 years Abscess Indian Positive Negative
M 44 years Abscess Canadian Positive Negative
M 14 years Abscess Qatari Positive Negative
M 40 years Abscess British Positive Negative
M 5 years Abscess British Negative Negative
M 46 years Abscess Indian Positive Negative
F 25 years Abscess Lebanese Negative Negative
M 15 years Abscess Tunisian Positive Negative EUST80; SCCmec IV; dt10a; t044; 80b
M 2 years Skin vesicles Lebanese Positive Negative
M 40 years Wound Canadian Positive Negative
F 13 years Abscess Qatari Positive Negative
M 31 years Nasal swab Syrian Positive Negative
M 1 year Skin vesicles Egyptian Positive Negative
M 35 years Abscess Egyptian Positive Negative
F 2 years Wound Egyptian Positive Negative
F 25 years HVS Qatari Negative Negative (Pediatric clone) USA 800; SCCmec IV; ND; t002; 5b
F 7 months Skin vesicles Qatari Negative Negative
M 39 years Wound Sudanese Negative Negative
F 1 years Abscess (groin) Pakistani Negative Negative
F 32 years Skin Pakistani Negative Negative
F 22 years Urine Qatari Negative Negative
M 3 years Pus, Abscess Qatari Negative Negative
F 20 years Abscess Qatari Negative Negative
M 3 years Abscess Qatari Negative Negative
M 29 years Abscess Qatari Negative Negative
M 44 years Eye swab Egyptian Negative Negative
F 32 years Abscess Sri Lankan Negative Negative
M 34 years Abscess Qatari Negative Negative
F 10 days Pus Egyptian Positive Negative (Southwest- Paciﬁc clone) USA 1100; SCCmec IV; ND; t019;
30bF 31 years Abscess Qatari Positive Negative
F 34 years Abscess Qatari Positive Negative
M 54 years Abscess American Positive Negative
M 37 years Abscess Qatari Positive Negative
F 29 years Abscess (arm) Iranian Positive Negative
F 33 years Wound British Positive Negative
F 3 years Abscess Indian Positive Negative
F 33 years Abscess British Positive Negative
F 3 years Wound Egyptian Positive Negative
M 41 years Wound Filipino Positive Negative
M 62 years Abscess Filipino Positive Negative
M 2 years Abscess Qatari Positive Negative
F 33 years Nasal swab Filipino Positive Negative
M 35 years Abscess Filipino Positive Negative
F 35 years Abscess Qatari Positive Negative
F 38 years Abscess Qatari Positive Negative
M 54 years Abscess Egyptian Positive Negative USA 1200 V ND t314 121
M 52 years Abscess American Positive Positive USA 300 IV dt9g t008 8
F 32 years Abscess Canadian Positive Positive USA 300 IV dt9g t121 8
M 35 years Abscess American Positive Positive USA 300 IV dt9g t008 8
F 32 years HVS Canadian Positive Positive USA 300 IV dt9g t121 8
F 37 years Wound Qatari Negative Negative USA 400 IV ND ND 8
F 54 years Abscess Bangladeshi Negative Negative USA 400 IV ND ND 8
M 44 years Wound Egyptian Negative Negative USA 400 IV ND t267 8
M 41 years Abscess Bahraini Positive Negative USA 900 V ND ND 15
M 45 years Abscess Qatari Positive Negative USA 900 V ND t657 15
F 48 years Abscess Indian Positive Negative USA 900 V ND t7358 15
M 8 days Skin vesicles Indian Positive Negative Unknown IV ND t690 88
M 34 years Wound Qatari Positive Negative Unknown IV ND t690 88
M 42 years Skin blister Filipino Negative Positive Unknown V ND UNK UNK
F 30 years HVS Qatari Negative Negative Unknown V ND UNK UNK
F, female; M, male; MLST, multilocus sequence typing; ND, not determined; PFGE, pulsed-ﬁeld gel electrophoresis; UNK, unknown; HVS, high vaginal swab.
aIn some instances, molecular characteristics were inferred from the strain type indicated by the PFGE pattern.
bspa, dru, SCCmec typing were performed on a representative subset of isolates.
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Analysis by PFGE demonstrated patterns in 32 isolates (52%)
consistent with a community-associated MRSA designation (i.e.
strain types previously described as community-associated
MRSA) [3,16]. The most prevalent clone was the PVL-positive
USA1100 (SW Paciﬁc Clone) which represented 28% (17
isolates) of the total number of isolates (Fig. 1). Well known
community-associated MRSA strains (ST80-MRSA-IV, USA300
and USA400) were 13% (eight isolates), 7%, (four isolates) and
5% (three isolates) of the total, respectively, cumulatively
representing 25% of all isolates. PFGE patterns for the remaining
isolates were consistent with a healthcare-associated MRSA
designation (strain types previously described as health-
care-associated MRSA) [3,16]. USA800 (Paediatric Clone)
isolates were 21% (13 isolates) of the total while 13% (eight
isolates) were a mixture of PVL-positive and PVL-negative
EMRSA-15.
In contrast to previous reports [20,21], in which USA900
and USA1200 were detected only as methicillin-sensitive
S. aureus, three MRSA isolates in the current study were
USA900, one was USA1200, and four were unrelated to any
known strains in the international database (two of them were
inferred to be ST88-MRSA-IV). Unexpectedly, the USA900
isolates were all positive for PVL and USA400 isolates were
PVL negative. USA400 isolates were cultured in the current
study from non-North American patients (i.e. patients from
Qatar, Bangladesh and Egypt).
In addition, ﬁve of the eight EMRSA-15 isolates were PVL
positive. This ﬁnding is surprising because previous studies
detected that all EMRSA-15 clone isolates were PVL negative
[22,23]. Sequence analysis of the mec-associated direct repeat
(dru) region in USA300 and ST80-MRSA-IV isolates yielded dru
types 9g and 10a, respectively, conﬁrming the clonal spread of
these strains as seen in other geographic locations [24–26]. As
expected, the ACME arcA gene was only found in USA300
isolates [12] and also in one additional strain that lysed poorly
and is the subject of further investigation. Eleven different spa
types were observed in this study. Two spa types (t008 ‘2’ and
t121 ‘2’) were associated with USA300 isolates. A USA300
clone was previously demonstrated to move from the
community to the hospital setting where it underwent an
adaptive process combining both resistance and virulence
characteristics [26,27].
Inducible clindamycin resistance was detected in 12 (20%)
isolates that were USA800 (ﬁve isolates), EMRSA-15 (three
isolates), ST80-MRSA-IV (two isolates), and individual isolates
of USA300 and the inferred ST88-MRSA-IV clone. These data
are in agreement with a previous report [28] where 20% of 60
MRSA isolated from clinical samples were found to have
inducible resistance to clindamycin detected by D-test.
Only ﬁve (8%) of our isolates were resistant to mupirocin.
According to the hospital’s infection control policy, mupirocin
nasal ointment was used routinely for MRSA decolonization
either in nasal carriers or for treatment of patients. In a
previous study, among 4980 MRSA isolates from 32 Canadian
hospitals, high-level mupirocin resistance increased from 1.6%
in 1995–99 to 7.0% in 2000–04 [29].
Conclusions
The predominant MRSA strain types found were USA1100
(SW Paciﬁc Clone), USA800 (Paediatric Clone) and EM-
RSA-15. The global spread of community-associated MRSA
strains continues unabated and clearly extends to the Middle
East. This not only includes ST80-MRSA-IV, which is well
known in Europe, but also USA300 and USA400 strains
typically associated with North America. Finding the USA300
clone in the Middle East region stresses the need for active and
continuous monitoring of the incidence of this threatening
clone.
The current study underscores the value of molecular
typing to monitor global trends in the emergence, spread and
persistence of epidemic MRSA strains. Our ﬁndings also
highlight the need for continued vigilance and surveillance.
According to our knowledge, this is the ﬁrst published
report concerning MRSA typing in Qatar; however, further
studies are still required in this area and in the Middle East as a
whole to compare the spread of different clones with ﬁndings
in other geographical regions in the world.
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